JP Morgan Chase
MAIA icon

JP Morgan Chase’s MAIA Biotechnology MAIA Stock Holding History

JP Morgan Chase’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26 Buy
+23
New +$31 ﹤0.01% 7959
2025
Q3 		– Sell
-50
Closed -$90 – 7602
2025
Q2 		$90 Buy
50
+8
+19% +$14 ﹤0.01% 6850
2025
Q1 		$64 Sell
42
-3
-7% -$6 ﹤0.01% 6937
2024
Q4 		$89 Sell
45
-2
-4% -$5 ﹤0.01% 7024
2024
Q3 		$132 Buy
47
+6
+15% +$19 ﹤0.01% 6963
2024
Q2 		$140 Buy
41
+3
+8% +$9 ﹤0.01% 6836
2024
Q1 		$84 Sell
38
-40
-51% -$60 ﹤0.01% 6938
2023
Q4 		$91 Buy
78
+67
+609% +$108 ﹤0.01% 7134
2023
Q3 		$24 Buy
+11
New +$22 ﹤0.01% 7137

Other funds holding MAIA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Centric Wealth Management
Centric Wealth Management Chicago, Illinois $657M AUM 18.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bleichroeder LP
Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Bleakley Financial Group
Bleakley Financial Group Fairfield, New Jersey $8.8B AUM 22.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase's MAIA Position: Q3 2026 in Review

JP Morgan Chase opened a new position in MAIA Biotechnology (MAIA) in Q3 2026: 23 shares worth $26. The stake represents ﹤0.01% of the portfolio and ranks #7959 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in MAIA as recently as Q2 2025.

JP Morgan Chase first reported a position in MAIA in Q3 2023 and has held it in 9 quarters since. The position peaked at $140 in Q2 2024. 31 funds tracked by Wall St. Rank hold MAIA as of Q3 2026.

  • JP Morgan Chase held 23 shares of MAIA Biotechnology worth $26 as of Q3 2026.
  • MAIA Biotechnology was a new JP Morgan Chase position in Q3 2026.
  • MAIA Biotechnology made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7959 holding.
  • JP Morgan Chase first reported a position in MAIA Biotechnology in Q3 2023 and has held it in 9 quarters since.
  • JP Morgan Chase's MAIA Biotechnology position peaked at $140 in Q2 2024.
  • 31 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.